> top > docs > PMC:7558233 > spans > 65-973 > annotations

PMC:7558233 / 65-973 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
13 250-261 Species denotes respiratory Tax:12814
14 0-24 Disease denotes Coronavirus disease 2019 MESH:C000657245
15 26-34 Disease denotes COVID-19 MESH:C000657245
16 61-83 Disease denotes coronavirus infections MESH:D018352
17 191-200 Disease denotes mortality MESH:D003643
18 282-314 Disease denotes Middle East respiratory syndrome MESH:D018352
19 316-320 Disease denotes MERS MESH:D018352
20 454-462 Disease denotes COVID-19 MESH:C000657245
21 639-648 Disease denotes infection MESH:D007239
22 766-774 Disease denotes COVID-19 MESH:C000657245
23 805-813 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T3 0-201 Sentence denotes Coronavirus disease 2019 (COVID-19)—the third in a series of coronavirus infections—has caused a global public health event in the 21st century, resulting in substantial global morbidity and mortality.
T4 202-523 Sentence denotes Building on its legacy of managing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), China has played a key role in the scientific community by revealing the viral transmission routes and clinical characteristics of COVID-19 and developing novel therapeutic interventions and vaccines.
T5 524-775 Sentence denotes Despite these rapid scientific and technological advances, uncertainties remain in tracing the original sources of infection, determining the routes of transmission and pathogenesis, and addressing the lack of targeted clinical management of COVID-19.
T6 776-908 Sentence denotes Here, we summarize the major COVID-19 research advances in China in order to provide useful information for global pandemic control.